Clinical Trials on Cardiovascular Disease Risk Factors in Japan

Total 1160 results

University of Oxford
British Heart Foundation; European Commission; Oxford University Hospitals NHS... and other collaborators

Recruiting

The Oxford Risk Factors And Non-Invasive Imaging Study (ORFAN)

Cardiovascular Diseases | Cardiovascular Risk Factors

United Kingdom, Germany, Belgium, China, United States, Australia, France, Greece, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Romania, United Arab Emirates
Kyoto University

Completed

Effect of Passive Exercise on Systemic Endothelial Function in Elderly Patients With Chronic Heart Failure

Elderly | Congestive Heart Failure | Endothelium-derived Factors

Japan
Novo Nordisk A/S
Sponsor: Corvidia Therapeutics Inc, a subsidiary of Novo Nordisk A/S

Completed

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. (RESCUE-2)

Inflammation | Chronic Kidney Disease | Cardiovascular Risk

Japan
Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes

Lower-risk Myelodysplastic

Japan
Bristol-Myers Squibb

Active, not recruiting

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

Lower-risk Myelodysplastic Syndromes

Japan
Chieko Hamada

Terminated

Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)

Cardiovascular Disease

Japan
Kumamoto University

Completed

Prognostic Value of Endothelial Dysfunction and Coronary Complexity

Cardiovascular Disease

Japan
Kyoto University, Graduate School of Medicine
Kyoto Prefectural University of Medicine

Withdrawn

Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study

Hypertension | Cardiovascular Disease | Vascular Disease

Japan
Janssen Pharmaceutical K.K.

Recruiting

A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer (TAR-210)

Urinary Bladder Neoplasms | Receptors, Fibroblast Growth Factor

Japan
Amgen

Completed

A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects (AMG145)

Hypercholesterolemia and High Risk for Cardiovascular Events

Japan
Seiji Umemoto, M.D., Ph.D.
Yamaguchi University Hospital; The Japanese Society of Hypertension; Kyowa Hakko...

Completed

Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients (COPE)

Cardiovascular Disease

Japan
Novo Nordisk A/S

Completed

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

Healthy Volunteers | Atherosclerotic Cardiovascular Disease

Japan
Okayama University

Completed

Cardiac Biomarker in Pediatric Heart Disease

Congenital Heart Disease

Japan
GlaxoSmithKline

Completed

Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects

Cardiovascular Disease

Japan
Kochi University
University of Tokushima; Oita University

Unknown

Tight Glycemic Control by Artificial Pancreas (KMS)

Cardiovascular Diseases | Pancreatic Disease

Japan
Amgen

Completed

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk (AMG145)

Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events

Japan
Novartis

Completed

SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension

Hypertension

Japan
Novartis

Completed

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Bayer

Completed

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Treatment of Venous Thromboembolism

Japan
Tokyo Medical and Dental University

Completed

Randomized Clinical Trial of Treatment for Temporomandibular Joint (TMJ) Disc Displacement

Temporomandibular Disorders | Herniated Disk

Japan
The Open University of Japan

Completed

Cost-effectiveness Analysis on Remote Monitoring for CIEDs in Japan by Using Systematic Review Methodology

Cardiovascular Diseases | Heart Failure

Japan
Takeda

Recruiting

A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure

Hypertension

Japan
Boehringer Ingelheim

Completed

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

Hypertension

Japan
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
Jichi Medical University

Completed

A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home) (Asia BP@Home)

Hypertension

Japan
Novartis

Completed

SPP100 Dose Finding Study in Japan

Hypertension

Japan
Jichi Medical University

Completed

The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

Hypertension

Japan
Abbott Medical Devices
Japanese society of Congenital Interventional Cardiology

Recruiting

Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance

Patent Ductus Arteriosus

Japan
Takeda

Completed

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

Hypertension

Japan
Takeda

Completed

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

Hypertension

Japan
Yoshio Matsui

Unknown

Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study

Hypertension

Japan
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.

Heart Failure

Japan
CAVI-J Study Group
Okayama University; Dokkyo Medical University; Ehime University Graduate School... and other collaborators

Completed

A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan (CAVI-J)

Stroke | Cardiovascular Death | Nonfatal Myocardial Infarction

Japan
Takashi Kubo, MD
Daiichi Sankyo, Inc.

Unknown

Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention (COCOA)

Coronary Disease

Japan
Medtronic Cardiac Rhythm and Heart Failure

Completed

MDT-1118 Japan DT Study (MDT-1118 Japan)

Heart Failure

Japan
Novartis

Completed

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

Essential Hypertension

Japan
Kyoto University

Completed

Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension

Essential Hypertension

Japan
Daiichi Sankyo Co., Ltd.

Completed

Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

Essential Hypertension

Japan
Daiichi Sankyo, Inc.

Completed

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

Essential Hypertension

Japan
Daiichi Sankyo Co., Ltd.

Completed

Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

Hypertension

Japan
Ibaraki Children's Hospital

Completed

Does Ketamine Attenuate Depression of Respiratory and Cardiac Functions

Congenital Heart Disease | Sedated for Cardiac Catheterization

Japan
Boehringer Ingelheim
Eli Lilly and Company

Active, not recruiting

Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF)

Heart Failure

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Patients With Severe Hypertension

Severe Hypertension

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

Essential Hypertension

Japan
Novartis

Completed

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Hypertension

Japan
Novartis

Completed

A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)

Hypertension

Japan
Tokyo University

Completed

Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine (ONEAST)

Essential Hypertension

Japan
Okayama University
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Completed

Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS)

Hypoplastic Left Heart Syndrome | Single Right Ventricle | Single Left Ventricle

Japan
Saga University

Active, not recruiting

Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

Heart Failure

Japan

3

Subscribe